1-20 of 21 Results

Title Investigator Disease(s)

AVID100 in Advanced Epithelial Carcinomas

[Protocol 18-1051]
Jessica Bauman
  • Multiple
  • Atezolizumab as Adjuvant after Local Therapy in Pts. c/High Risk Squamous Cell of H&N

    [Protocol 18-1007]
    Jessica Bauman
  • Multiple
  • Cohort to Address Racial Disparities in Head and Neck Cancer Survival

    [Protocol IRB13820]
    Camille Ragin
  • Multiple
  • Concurrent Radiation + Chemotherapy vs Radiation Alone in High-Risk Malignant Salivary Gland Tumors

    [Protocol RTOG1008]
    Thomas Galloway
  • Lip, Oral Cavity and Pharynx
  • Durvalumab v cetuximab + RT for patients not eligible for cisplatin chemoRT

    [Protocol 18-2003]
    Thomas Galloway
  • Multiple
  • Efficacy, Safety & Tolerability of AG013 in Oral Mucositis Compared to Placebo

    [Protocol 19-1005]
    Curtis Miyamoto
  • Multiple
  • Evaluation of BMS-986226 Alone or in Combination w/Opdivo or Yervoy in Pts w/Advanced Solid Tumors

    [Protocol 17-1046]
    Jessica Bauman
  • Multiple
  • Examination of Tipifarnib in Advanced Non-Hematological Malignancies with HRAS Mutations

    [Protocol 15-1008]
    Jessica Bauman
  • Multiple
  • Ficlatuzumab w/ or w/out Cetux in Pts w/ Cetux-Resistant, Recurrent/Metastatic HNSCC

    [Protocol 18-1020]
    Yanis Boumber
  • Multiple
  • Gene-Environment Interactions and Racial Disparities in Head and Neck Cancer- A Case-Control Study

    [Protocol IRB13819]
    Camille Ragin
  • Multiple
  • Molecular Analysis for Therapy Choice (MATCH)

    [Protocol 15-7002]
    Lori Goldstein
  • Multiple
  • ONC201 Administered Every One or Three Weeks in Advanced Solid Tumors and Multiple Myeloma

    [Protocol 15-1009]
    Anthony Olszanski
  • Multiple
  • Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma

    [Protocol 17-2011]
    Curtis Miyamoto
  • Brain and Nervous System
  • Oral 5-iodo-2-pyrimidinone-2-deoxyribose (IPdR) as a Prodrug for IUdR-Mediated Tumor Radiosensitizat

    [Protocol 18-1005]
    Stephanie Weiss
  • Brain and Nervous System
  • Perioperative Risk study in Patients Undergoing Elective Major Cancer Surgery

    [Protocol 14-036]
    Marc Smaldone
  • Multiple
  • Phase II/III De-I for favorable p16-positive OPC

    [Protocol 19-2014]
    Thomas Galloway
  • Lip, Oral Cavity and Pharynx
  • Prospective Study of Swallowing Function in Head and Neck Cancer Patients

    [Protocol IRB05856]
    Barbara Ebersole
  • Lip, Oral Cavity and Pharynx
  • Radiotherapy +/- Cisplatin for Squamous Cell Carcinoma of the Head/Neck (SCCHN) w/TP53 Sequencing

    [Protocol 16-2003]
    Thomas Galloway
  • Multiple
  • Reirradiation + Keytruda in Patients with Squamous Cell Carcinoma of the Head and Neck (SCCHN)

    [Protocol 15-1043]
    Thomas Galloway
  • Multiple
  • Risk Assessment Program (RAP) Registry

    [Protocol IRB09831]
    Mary Daly
  • Multiple